factor | No. of cases | OCR deaths (%|) | HR | CI (95%) | P-value | |
Age at diagnosis | 50 - 55 | 32 | 15 (46.8%) | 0.67 | 0.47 - 0.95 | 0.06 |
56 - 60 | 40 | 18 (45%) | 0.64 | 0.73 - 1.02 | ||
61 - 65 | 33 | 21 (63.3%) | 0.88 | 0.64 - 1,12 | ||
65 - 70 | 25 | 19 (76%) | 1.03 | 0.75 - 1.23 | ||
Histology | Serous | 82 | 49 (59.7%) | 0.98 | 0.67 - 1.34 | 0.76 |
Mucinous | 25 | 14 (56%) | 1.00 | 0.65 - 1.23 | ||
Clear cell | 5 | 3 (60%) | 089 | 0.71 - 1.29 | ||
Endometroid | 11 | 6 (54%) | 0.93 | 0.68 - 1.34 | ||
Undifferetiated | 7 | 4 (57%) | 097 | 0.71 - 1.34 | ||
Stage | III | 115 | 79 (68.6%) | 1 | - | 0.01 |
IV | 15 | 11 (73.3%) | 0.5 | 0.61 - 0.85 | ||
Grade of differetiation | Well | 60 | 20 (30%) | 1 | - | 0.06 |
Moderate | 40 | 25 (62%) | 1.34 | 0.98 - 1.67 | ||
Poor | 30 | 21 (70%) | 1.54 | 0.87 - 1.87 | ||
Residual tumor | 0 | 82 | 23 (28%) | 1 | - | 0.002 |
<2cm | 32 | 10 (31.3%) | 1.33 | 1.07 - 1.64 | ||
>2cm | 10 | 6 (60%) | 1.47 | 1.23 - 1.77 | ||
Response to NACT | Responding | 49 | 30 (61%) | 1 | - | 0.03 |
No responding | 16 | 12 (75%) | 1.67 | 1.34 - 2.07 |